SMS Pharma.

{
  "main_header": {
    "sid": 517655,
    "name": "SMS Pharma.",
    "stock_name": "SMS Pharma.",
    "full_name": "SMS Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sms-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "399.10",
    "chg": 6.4,
    "chgp": "1.63%",
    "dir": 1,
    "prev_price": "392.70",
    "mcapval": "3,737.65 Cr",
    "mcap": "Small Cap",
    "scripcode": 532815,
    "symbol": "SMSPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE812G01025",
    "curr_date": "Sep 07, 03:13 PM",
    "curr_time": "15:14 PM",
    "last_traded_at": "Sep 07, 03:13 PM IST",
    "bse_nse_vol": "37.12 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 07, 2026",
    "traded_date_str": "2026 09 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "SMS Pharmaceuticals Ltd Surges 8.15% to Day's High of Rs 424.8 — Outperforms Sector by 7.8 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-strong-815-surge-4184873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SMSPharmaceutic_priceRelatedfactors_4184873.png",
        "date": "2026-09-07 10:21:40",
        "description": "The Sensex declined 0.43% on 07 Sep 2026, while SMS Pharmaceuticals Ltd surged 8.15%, touching an intraday high of Rs 424.8. This 7.8-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-risk-amid-strong-returns-4184378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SMSPharmaceutic_valuationdot_4184378.png",
        "date": "2026-09-07 08:00:20",
        "description": "SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, despite delivering robust stock returns well above the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid the company’s evolving market position."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4176018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SMSPharmaceutic_mojoScore_4176018.png",
        "date": "2026-08-31 10:10:21",
        "description": "SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4162490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SMSPharmaceutic_mojoScore_4162490.png",
        "date": "2026-08-20 10:10:40",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4144022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SMSPharmaceutic_mojoScore_4144022.png",
        "date": "2026-08-09 10:10:17",
        "description": "SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 August 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Are SMS Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sms-pharmaceuticals-ltd-latest-results-good-or-bad-4132619",
        "imagepath": "",
        "date": "2026-08-02 19:12:30",
        "description": "The latest financial results for SMS Pharmaceuticals Ltd for the quarter ended June 2026 present a mixed operational picture. The company reported a consolidated net profit of ₹20.91 crores, reflecting a year-on-year growth of 2.05%, which indicates some resilience compared to the same period last year. However, this figure represents a significant quarter-on-quarter decline of 36.07% from ₹32.71 crores in March 2026, highlighting volatility in profitability.\n\nIn terms of revenue, SMS Pharmaceuticals achieved net sales of ₹206.96 crores, which marks a year-on-year increase of 5.56% from ₹196.05 crores in June 2025. Conversely, the sequential comparison shows a decline of 13.02% from ₹237.95 crores in the previous quarter, suggesting challenges in maintaining consistent sales momentum.\n\nDespite the pressures on sales and profit, the company demonstrated effective cost management, as evidenced by an operating..."
      },
      {
        "title": "SMS Pharmaceuticals Q1 FY27: Margin Resilience Amid Revenue Headwinds",
        "link": "https://www.marketsmojo.com/news/result-analysis/sms-pharmaceuticals-q1-fy27-margin-resilience-amid-revenue-headwinds-4131656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SMSPharmaceutic_quaterlyResult_4131656.png",
        "date": "2026-08-01 13:17:37",
        "description": "SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients (API) manufacturer, reported a mixed performance for Q1 FY27 (June 2026 quarter), with consolidated net profit rising 2.05% year-on-year to ₹20.91 crores despite a 13.02% sequential revenue decline. The ₹3,526 crore market capitalisation company demonstrated margin resilience even as topline pressures emerged, raising questions about sustainability of growth momentum in an increasingly competitive pharmaceutical landscape."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-amidst-market-volatility-4129404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SMSPharmaceutic_valuationdot_4129404.png",
        "date": "2026-07-31 08:00:24",
        "description": "SMS Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects evolving market perceptions and valuation dynamics within the Pharmaceuticals & Biotechnology sector. This article examines the implications of these valuation changes, comparing SMS Pharma’s metrics against its peers and historical benchmarks to assess its price attractiveness and investment appeal."
      },
      {
        "title": "When is the next results date for SMS Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sms-pharmaceuticals-ltd-4129188",
        "imagepath": "",
        "date": "2026-07-30 23:16:50",
        "description": "The next results date for SMS Pharmaceuticals Ltd is scheduled for August 1, 2026...."
      }
    ],
    "total": 789,
    "sid": "517655",
    "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Sep-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 38Th Annual General Meeting To Be Held On 29Th September 2026",
      "datetime": "04-Sep-2026",
      "details": "Notice of 38th Annual General Meeting for the FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
      "datetime": "04-Sep-2026",
      "details": "BRSR for the Financial Year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 26",
          "dt": "2026-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15",
          "dt": "2015-12-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

SMS Pharmaceuticals Ltd Surges 8.15% to Day's High of Rs 424.8 — Outperforms Sector by 7.8 Percentage Points

2026-09-07 10:21:40

The Sensex declined 0.43% on 07 Sep 2026, while SMS Pharmaceuticals Ltd surged 8.15%, touching an intraday high of Rs 424.8. This 7.8-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns

2026-09-07 08:00:20

SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, despite delivering robust stock returns well above the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid the company’s evolving market position.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-08-31 10:10:21

SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-08-20 10:10:40

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-08-09 10:10:17

SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 August 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

Are SMS Pharmaceuticals Ltd latest results good or bad?

2026-08-02 19:12:30

The latest financial results for SMS Pharmaceuticals Ltd for the quarter ended June 2026 present a mixed operational picture. The company reported a consolidated net profit of ₹20.91 crores, reflecting a year-on-year growth of 2.05%, which indicates some resilience compared to the same period last year. However, this figure represents a significant quarter-on-quarter decline of 36.07% from ₹32.71 crores in March 2026, highlighting volatility in profitability. In terms of revenue, SMS Pharmaceuticals achieved net sales of ₹206.96 crores, which marks a year-on-year increase of 5.56% from ₹196.05 crores in June 2025. Conversely, the sequential comparison shows a decline of 13.02% from ₹237.95 crores in the previous quarter, suggesting challenges in maintaining consistent sales momentum. Despite the pressures on sales and profit, the company demonstrated effective cost management, as evidenced by an operating...

Read full news article

SMS Pharmaceuticals Q1 FY27: Margin Resilience Amid Revenue Headwinds

2026-08-01 13:17:37

SMS Pharmaceuticals Ltd., a Hyderabad-based active pharmaceutical ingredients (API) manufacturer, reported a mixed performance for Q1 FY27 (June 2026 quarter), with consolidated net profit rising 2.05% year-on-year to ₹20.91 crores despite a 13.02% sequential revenue decline. The ₹3,526 crore market capitalisation company demonstrated margin resilience even as topline pressures emerged, raising questions about sustainability of growth momentum in an increasingly competitive pharmaceutical landscape.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility

2026-07-31 08:00:24

SMS Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects evolving market perceptions and valuation dynamics within the Pharmaceuticals & Biotechnology sector. This article examines the implications of these valuation changes, comparing SMS Pharma’s metrics against its peers and historical benchmarks to assess its price attractiveness and investment appeal.

Read full news article

When is the next results date for SMS Pharmaceuticals Ltd?

2026-07-30 23:16:50

The next results date for SMS Pharmaceuticals Ltd is scheduled for August 1, 2026....

Read full news article

View All News